Why the study?
Do aspirin, dipyridamole, or ticlopidine reduce ADP-induced alpha-granule release from platelets in native whole blood?
Population
Native whole blood
Design
Preclinical
Authors
Loading...
Ticlopidine may selectively inhibit early platelet activation in animals; leaves open translation to human antiplatelet regimens.
Do aspirin, dipyridamole, or ticlopidine reduce ADP-induced alpha-granule release from platelets in native whole blood?
Ticlopidine, unlike aspirin or dipyridamole, reduces ADP-induced platelet alpha-granule release, highlighting its specific mechanism in inhibiting early platelet activation.
Pengo et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: